A detailed history of California State Teachers Retirement System transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 13,692 shares of ESPR stock, worth $28,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,692
Previous 13,692 -0.0%
Holding current value
$28,753
Previous $30,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.84 - $3.24 $25,193 - $44,362
13,692 New
13,692 $30,000
Q1 2023

May 09, 2023

BUY
$1.46 - $7.3 $27,656 - $138,283
18,943 Added 24.11%
97,511 $155,000
Q4 2022

Feb 14, 2023

BUY
$5.09 - $8.5 $266,079 - $444,337
52,275 Added 198.82%
78,568 $489,000
Q3 2022

Nov 18, 2022

SELL
$5.45 - $8.13 $3,678 - $5,487
-675 Reduced 2.5%
26,293 $176,000
Q2 2022

Aug 15, 2022

BUY
$4.77 - $6.67 $10,608 - $14,834
2,224 Added 8.99%
26,968 $172,000
Q1 2022

May 16, 2022

BUY
$3.34 - $5.56 $35,367 - $58,874
10,589 Added 74.81%
24,744 $115,000
Q4 2021

Feb 15, 2022

SELL
$4.81 - $11.92 $97,186 - $240,843
-20,205 Reduced 58.8%
14,155 $71,000
Q3 2021

Nov 15, 2021

SELL
$11.34 - $21.37 $20,729 - $39,064
-1,828 Reduced 5.05%
34,360 $414,000
Q2 2021

Aug 16, 2021

SELL
$19.4 - $28.71 $55,309 - $81,852
-2,851 Reduced 7.3%
36,188 $765,000
Q1 2021

May 18, 2021

SELL
$25.12 - $36.89 $3,793 - $5,570
-151 Reduced 0.39%
39,039 $1.1 Million
Q3 2020

Nov 17, 2020

BUY
$31.18 - $52.71 $4,864 - $8,222
156 Added 0.4%
39,190 $1.46 Million
Q2 2020

Aug 17, 2020

BUY
$30.04 - $51.31 $24,062 - $41,099
801 Added 2.1%
39,034 $2 Million
Q1 2020

May 13, 2020

SELL
$27.44 - $73.84 $11,826 - $31,825
-431 Reduced 1.11%
38,233 $1.21 Million
Q4 2019

Feb 14, 2020

SELL
$35.4 - $59.82 $6,726 - $11,365
-190 Reduced 0.49%
38,664 $2.31 Million
Q3 2019

Nov 15, 2019

BUY
$34.47 - $47.53 $15,994 - $22,053
464 Added 1.21%
38,854 $1.42 Million
Q2 2019

Aug 14, 2019

BUY
$40.1 - $52.33 $124,310 - $162,223
3,100 Added 8.78%
38,390 $1.79 Million
Q1 2019

May 09, 2019

SELL
$40.11 - $53.57 $22,301 - $29,784
-556 Reduced 1.55%
35,290 $1.42 Million
Q4 2018

Feb 13, 2019

BUY
$36.99 - $59.11 $27,631 - $44,155
747 Added 2.13%
35,846 $1.65 Million
Q3 2018

Nov 14, 2018

BUY
$40.74 - $51.41 $3,299 - $4,164
81 Added 0.23%
35,099 $1.56 Million
Q2 2018

Aug 14, 2018

BUY
$36.2 - $76.4 $313,709 - $662,082
8,666 Added 32.89%
35,018 $1.37 Million
Q1 2018

May 15, 2018

SELL
$65.94 - $80.76 $26,046 - $31,900
-395 Reduced 1.48%
26,352 $1.91 Million
Q4 2017

Feb 14, 2018

SELL
$43.47 - $67.43 $17,692 - $27,444
-407 Reduced 1.5%
26,747 $1.76 Million
Q3 2017

Nov 13, 2017

BUY
$43.8 - $52.77 $1.19 Million - $1.43 Million
27,154
27,154 $1.36 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $140M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.